_id
6915f0ecbc934aba376b2052
Ticker
RPRX
Name
Royalty Pharma Plc
Exchange
NASDAQ
Address
110 East 59th Street, New York, NY, United States, 10022
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.royaltypharma.com
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Last Close
38.81
Volume
4233061
Current Price
38.39
Change
-1.0821953104869921
Last Updated
2025-12-03T13:06:38.821Z
Image
data:image/webp;base64,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
Ipo Date
1993-03-25T00:00:00.000Z
Market Cap
23052877824
Next Dividend Date
2025-12-10T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.22
Dividend Yield
2.292263610315186
Sentiment
0.9029230769230769
Sentiment Sources
26
Rating
4.25
Target Price
45.9844
Strong Buy
4
Buy
2
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
609291000
Cost Of Revenue
1277000
Gross Profit
609291000
Operating Expenses
182135000
Operating Income
427156000
Interest Expense
79564000
Pretax Income
444211000
Net Income
288217000
Eps
0.5150309768750079
Dividends Per Share
95312000
Shares Outstanding
427247489
Income Tax Expense
155994000
EBITDA
525052000
Operating Margin
70.10705886021623
Total Other Income Expense Net
17055000
Cash
938944000
Short Term Investments
16100000
Receivables
888974000
Inventories
-
Total Current Assets
1849537000
Property Plant Equipment
19800000
Total Assets
19347280000
Payables
41415000
Short Term Debt
383119000
Long Term Debt
8565735000
Total Liabilities
9726419000
Equity
6414348000
Depreciation
1277000
Change In Working Capital
-711742000
Cash From Operations
639627000
Capital Expenditures
1114000
Cash From Investing
-900150000
Cash From Financing
567559000
Net Change In Cash
307036000
PE
22.7184
PB
3.3492829341345374
ROE
4.493317169570469
ROA
1.4897029453235804
FCF
638513000
Fcf Percent
1.0479606624749094
Piotroski FScore
4
Health Score
59
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
4
Economic Moat Investing Score
7.8
Garp Investing Score
6
Growth Investing Score
5.5
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
7.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
609291000
Quarters > 0 > income Statement > cost Of Revenue
1277000
Quarters > 0 > income Statement > gross Profit
609291000
Quarters > 0 > income Statement > operating Expenses
182135000
Quarters > 0 > income Statement > operating Income
427156000
Quarters > 0 > income Statement > interest Expense
79564000
Quarters > 0 > income Statement > pretax Income
444211000
Quarters > 0 > income Statement > net Income
288217000
Quarters > 0 > income Statement > eps
0.5150309768750079
Quarters > 0 > income Statement > dividends Per Share
95312000
Quarters > 0 > income Statement > shares Outstanding
559611000
Quarters > 0 > income Statement > income Tax Expense
155994000
Quarters > 0 > income Statement > EBITDA
525052000
Quarters > 0 > income Statement > operating Margin
70.10705886021623
Quarters > 0 > income Statement > total Other Income Expense Net
17055000
Quarters > 0 > balance Sheet > cash
938944000
Quarters > 0 > balance Sheet > short Term Investments
16100000
Quarters > 0 > balance Sheet > receivables
888974000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1849537000
Quarters > 0 > balance Sheet > property Plant Equipment
19800000
Quarters > 0 > balance Sheet > total Assets
19347280000
Quarters > 0 > balance Sheet > payables
41415000
Quarters > 0 > balance Sheet > short Term Debt
383119000
Quarters > 0 > balance Sheet > long Term Debt
8565735000
Quarters > 0 > balance Sheet > total Liabilities
9726419000
Quarters > 0 > balance Sheet > equity
6414348000
Quarters > 0 > cash Flow > net Income
-463609000
Quarters > 0 > cash Flow > depreciation
1277000
Quarters > 0 > cash Flow > change In Working Capital
-711742000
Quarters > 0 > cash Flow > cash From Operations
639627000
Quarters > 0 > cash Flow > capital Expenditures
1114000
Quarters > 0 > cash Flow > cash From Investing
-900150000
Quarters > 0 > cash Flow > cash From Financing
567559000
Quarters > 0 > cash Flow > net Change In Cash
307036000
Quarters > 0 > ratios > PE
0.5150309768750079
Quarters > 0 > ratios > PB
3.3492829341345374
Quarters > 0 > ratios > ROE
4.493317169570469
Quarters > 0 > ratios > ROA
1.4897029453235804
Quarters > 0 > ratios > FCF
638513000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
1.0479606624749094
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
578665000
Quarters > 1 > income Statement > cost Of Revenue
203938000
Quarters > 1 > income Statement > gross Profit
578665000
Quarters > 1 > income Statement > operating Expenses
368866000
Quarters > 1 > income Statement > operating Income
209799000
Quarters > 1 > income Statement > interest Expense
68668000
Quarters > 1 > income Statement > pretax Income
90635000
Quarters > 1 > income Statement > net Income
30176000
Quarters > 1 > income Statement > eps
0.05369395017793594
Quarters > 1 > income Statement > dividends Per Share
93241000
Quarters > 1 > income Statement > shares Outstanding
562000000
Quarters > 1 > income Statement > income Tax Expense
60459000
Quarters > 1 > income Statement > EBITDA
159303000
Quarters > 1 > income Statement > operating Margin
36.255691980679664
Quarters > 1 > income Statement > total Other Income Expense Net
-119164000
Quarters > 1 > balance Sheet > cash
631908000
Quarters > 1 > balance Sheet > short Term Investments
856138000
Quarters > 1 > balance Sheet > receivables
27743000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1520241000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
18323000000
Quarters > 1 > balance Sheet > payables
20209000
Quarters > 1 > balance Sheet > short Term Debt
999436000
Quarters > 1 > balance Sheet > long Term Debt
7003063000
Quarters > 1 > balance Sheet > total Liabilities
8820060000
Quarters > 1 > balance Sheet > equity
6347910000
Quarters > 1 > cash Flow > net Income
30176000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
776218000
Quarters > 1 > cash Flow > cash From Operations
426972000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-370146000
Quarters > 1 > cash Flow > cash From Financing
-512638000
Quarters > 1 > cash Flow > net Change In Cash
-455812000
Quarters > 1 > ratios > PE
0.05369395017793594
Quarters > 1 > ratios > PB
3.398784796885904
Quarters > 1 > ratios > ROE
0.47536905847751465
Quarters > 1 > ratios > ROA
0.16468918845167277
Quarters > 1 > ratios > FCF
426972000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.7378569638737439
Quarters > 1 > health Score
55
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
568247000
Quarters > 2 > income Statement > cost Of Revenue
127140000
Quarters > 2 > income Statement > gross Profit
568247000
Quarters > 2 > income Statement > operating Expenses
34065000
Quarters > 2 > income Statement > operating Income
534182000
Quarters > 2 > income Statement > interest Expense
65261000
Quarters > 2 > income Statement > pretax Income
433433000
Quarters > 2 > income Statement > net Income
238349000
Quarters > 2 > income Statement > eps
0.41236851211072667
Quarters > 2 > income Statement > dividends Per Share
95357000
Quarters > 2 > income Statement > shares Outstanding
578000000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
498694000
Quarters > 2 > income Statement > operating Margin
94.00524771798179
Quarters > 2 > income Statement > total Other Income Expense Net
-100749000
Quarters > 2 > balance Sheet > cash
1087720000
Quarters > 2 > balance Sheet > short Term Investments
728659000
Quarters > 2 > balance Sheet > receivables
23785000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1843243000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
17608256000
Quarters > 2 > balance Sheet > payables
37630000
Quarters > 2 > balance Sheet > short Term Debt
998605000
Quarters > 2 > balance Sheet > long Term Debt
6618847000
Quarters > 2 > balance Sheet > total Liabilities
7819599000
Quarters > 2 > balance Sheet > equity
6688647000
Quarters > 2 > cash Flow > net Income
433433000
Quarters > 2 > cash Flow > depreciation
203818000
Quarters > 2 > cash Flow > change In Working Capital
-64476000
Quarters > 2 > cash Flow > cash From Operations
596076000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
503917000
Quarters > 2 > cash Flow > cash From Financing
-941299000
Quarters > 2 > cash Flow > net Change In Cash
158694000
Quarters > 2 > ratios > PE
0.41236851211072667
Quarters > 2 > ratios > PB
3.3174751186600218
Quarters > 2 > ratios > ROE
3.5634860084558206
Quarters > 2 > ratios > ROA
1.3536207106484595
Quarters > 2 > ratios > FCF
596076000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
1.0489734217690547
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
593641000
Quarters > 3 > income Statement > cost Of Revenue
164036000
Quarters > 3 > income Statement > gross Profit
593641000
Quarters > 3 > income Statement > operating Expenses
232127000
Quarters > 3 > income Statement > operating Income
361514000
Quarters > 3 > income Statement > interest Expense
65761000
Quarters > 3 > income Statement > pretax Income
334351000
Quarters > 3 > income Statement > net Income
208214000
Quarters > 3 > income Statement > eps
0.35350424448217316
Quarters > 3 > income Statement > dividends Per Share
93656000
Quarters > 3 > income Statement > shares Outstanding
589000000
Quarters > 3 > income Statement > income Tax Expense
126000000
Quarters > 3 > income Statement > EBITDA
400112000
Quarters > 3 > income Statement > operating Margin
60.897747965521255
Quarters > 3 > income Statement > total Other Income Expense Net
-27163000
Quarters > 3 > balance Sheet > cash
929026000
Quarters > 3 > balance Sheet > short Term Investments
841970000
Quarters > 3 > balance Sheet > receivables
26956000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1802139000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
18222715000
Quarters > 3 > balance Sheet > payables
13370000
Quarters > 3 > balance Sheet > short Term Debt
997773000
Quarters > 3 > balance Sheet > long Term Debt
6614653000
Quarters > 3 > balance Sheet > total Liabilities
7880349000
Quarters > 3 > balance Sheet > equity
6946581000
Quarters > 3 > cash Flow > net Income
334351000
Quarters > 3 > cash Flow > depreciation
307486000
Quarters > 3 > cash Flow > change In Working Capital
51519000
Quarters > 3 > cash Flow > cash From Operations
742525000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-505588000
Quarters > 3 > cash Flow > cash From Financing
-257963000
Quarters > 3 > cash Flow > net Change In Cash
-21026000
Quarters > 3 > ratios > PE
0.35350424448217316
Quarters > 3 > ratios > PB
3.2550847676000614
Quarters > 3 > ratios > ROE
2.9973594204112786
Quarters > 3 > ratios > ROA
1.1426069057217874
Quarters > 3 > ratios > FCF
742525000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
1.250798041240413
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2263576000
Annuals > 0 > income Statement > cost Of Revenue
732461000
Annuals > 0 > income Statement > gross Profit
2263576000
Annuals > 0 > income Statement > operating Expenses
971132000
Annuals > 0 > income Statement > operating Income
1292444000
Annuals > 0 > income Statement > interest Expense
225512000
Annuals > 0 > income Statement > pretax Income
1330813000
Annuals > 0 > income Statement > net Income
858983000
Annuals > 0 > income Statement > eps
1.4460993265993265
Annuals > 0 > income Statement > dividends Per Share
376465000
Annuals > 0 > income Statement > shares Outstanding
594000000
Annuals > 0 > income Statement > income Tax Expense
472000000
Annuals > 0 > income Statement > EBITDA
1556325000
Annuals > 0 > income Statement > operating Margin
57.09744227717558
Annuals > 0 > income Statement > total Other Income Expense Net
38369000
Annuals > 0 > balance Sheet > cash
929026000
Annuals > 0 > balance Sheet > short Term Investments
841970000
Annuals > 0 > balance Sheet > receivables
26956000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1802139000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
18222715000
Annuals > 0 > balance Sheet > payables
13370000
Annuals > 0 > balance Sheet > short Term Debt
997773000
Annuals > 0 > balance Sheet > long Term Debt
6614653000
Annuals > 0 > balance Sheet > total Liabilities
7880349000
Annuals > 0 > balance Sheet > equity
6946581000
Annuals > 0 > cash Flow > net Income
1330813000
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
53383000
Annuals > 0 > cash Flow > cash From Operations
2768986000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-2678115000
Annuals > 0 > cash Flow > cash From Financing
361145000
Annuals > 0 > cash Flow > net Change In Cash
452016000
Annuals > 0 > ratios > PE
1.4460993265993265
Annuals > 0 > ratios > PB
3.380198114727231
Annuals > 0 > ratios > ROE
12.36555076518938
Annuals > 0 > ratios > ROA
4.713803623664202
Annuals > 0 > ratios > FCF
2768986000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
1.2232794480945195
Annuals > 0 > health Score
67
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2354554000
Annuals > 1 > income Statement > cost Of Revenue
560656000
Annuals > 1 > income Statement > gross Profit
2354554000
Annuals > 1 > income Statement > operating Expenses
862404000
Annuals > 1 > income Statement > operating Income
1492150000
Annuals > 1 > income Statement > interest Expense
187187000
Annuals > 1 > income Statement > pretax Income
1700088000
Annuals > 1 > income Statement > net Income
1134834000
Annuals > 1 > income Statement > eps
1.8822922541051583
Annuals > 1 > income Statement > dividends Per Share
358327000
Annuals > 1 > income Statement > shares Outstanding
602900000
Annuals > 1 > income Statement > income Tax Expense
565254000
Annuals > 1 > income Statement > EBITDA
1887275000
Annuals > 1 > income Statement > operating Margin
63.3729360210044
Annuals > 1 > income Statement > total Other Income Expense Net
207938000
Annuals > 1 > balance Sheet > cash
477010000
Annuals > 1 > balance Sheet > short Term Investments
756738000
Annuals > 1 > balance Sheet > receivables
22405000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1274193000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
16381851000
Annuals > 1 > balance Sheet > payables
15165000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
6135285000
Annuals > 1 > balance Sheet > total Liabilities
6297562000
Annuals > 1 > balance Sheet > equity
6526497000
Annuals > 1 > cash Flow > net Income
1700088000
Annuals > 1 > cash Flow > depreciation
20499000
Annuals > 1 > cash Flow > change In Working Capital
5382000
Annuals > 1 > cash Flow > cash From Operations
2987802000
Annuals > 1 > cash Flow > capital Expenditures
2115522000
Annuals > 1 > cash Flow > cash From Investing
-2072789000
Annuals > 1 > cash Flow > cash From Financing
-2148754000
Annuals > 1 > cash Flow > net Change In Cash
-1233741000
Annuals > 1 > ratios > PE
1.8822922541051583
Annuals > 1 > ratios > PB
3.6516736313523164
Annuals > 1 > ratios > ROE
17.388102683568228
Annuals > 1 > ratios > ROA
6.927385678211821
Annuals > 1 > ratios > FCF
872280000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.37046506472138674
Annuals > 1 > health Score
80
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2237215000
Annuals > 2 > income Statement > cost Of Revenue
904244000
Annuals > 2 > income Statement > gross Profit
2237215000
Annuals > 2 > income Statement > operating Expenses
1930150000
Annuals > 2 > income Statement > operating Income
307065000
Annuals > 2 > income Statement > interest Expense
187961000
Annuals > 2 > income Statement > pretax Income
230064000
Annuals > 2 > income Statement > net Income
42832000
Annuals > 2 > income Statement > eps
0.09779620615016485
Annuals > 2 > income Statement > dividends Per Share
333322000
Annuals > 2 > income Statement > shares Outstanding
437972000
Annuals > 2 > income Statement > income Tax Expense
187232000
Annuals > 2 > income Statement > EBITDA
423695000
Annuals > 2 > income Statement > operating Margin
13.725323672512477
Annuals > 2 > income Statement > total Other Income Expense Net
-77001000
Annuals > 2 > balance Sheet > cash
1710751000
Annuals > 2 > balance Sheet > short Term Investments
717040000
Annuals > 2 > balance Sheet > receivables
36597000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
2554908000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
16813466000
Annuals > 2 > balance Sheet > payables
7906000
Annuals > 2 > balance Sheet > short Term Debt
997512000
Annuals > 2 > balance Sheet > long Term Debt
6118810000
Annuals > 2 > balance Sheet > total Liabilities
7288093000
Annuals > 2 > balance Sheet > equity
5628150000
Annuals > 2 > cash Flow > net Income
230064000
Annuals > 2 > cash Flow > depreciation
5670000
Annuals > 2 > cash Flow > change In Working Capital
32662000
Annuals > 2 > cash Flow > cash From Operations
2143980000
Annuals > 2 > cash Flow > capital Expenditures
2041152000
Annuals > 2 > cash Flow > cash From Investing
-1029421000
Annuals > 2 > cash Flow > cash From Financing
-944856000
Annuals > 2 > cash Flow > net Change In Cash
169703000
Annuals > 2 > ratios > PE
0.09779620615016485
Annuals > 2 > ratios > PB
3.0761499178237965
Annuals > 2 > ratios > ROE
0.761031600081732
Annuals > 2 > ratios > ROA
0.25474818814871364
Annuals > 2 > ratios > FCF
102828000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.04596250248635022
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2289463000
Annuals > 3 > income Statement > cost Of Revenue
452842000
Annuals > 3 > income Statement > gross Profit
2289463000
Annuals > 3 > income Statement > operating Expenses
858748000
Annuals > 3 > income Statement > operating Income
1430715000
Annuals > 3 > income Statement > interest Expense
166142000
Annuals > 3 > income Statement > pretax Income
1241201000
Annuals > 3 > income Statement > net Income
619728000
Annuals > 3 > income Statement > eps
1.4940332978143789
Annuals > 3 > income Statement > dividends Per Share
285184000
Annuals > 3 > income Statement > shares Outstanding
414802000
Annuals > 3 > income Statement > income Tax Expense
762447000
Annuals > 3 > income Statement > EBITDA
1430339000
Annuals > 3 > income Statement > operating Margin
62.49129162602759
Annuals > 3 > income Statement > total Other Income Expense Net
-189514000
Annuals > 3 > balance Sheet > cash
1541048000
Annuals > 3 > balance Sheet > short Term Investments
1262223000
Annuals > 3 > balance Sheet > receivables
68309000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
2878211000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
17515865000
Annuals > 3 > balance Sheet > payables
5620000
Annuals > 3 > balance Sheet > short Term Debt
6891670000
Annuals > 3 > balance Sheet > long Term Debt
7096070000
Annuals > 3 > balance Sheet > total Liabilities
7267320000
Annuals > 3 > balance Sheet > equity
5776594000
Annuals > 3 > cash Flow > net Income
1241201000
Annuals > 3 > cash Flow > depreciation
22996000
Annuals > 3 > cash Flow > change In Working Capital
-16322000
Annuals > 3 > cash Flow > cash From Operations
2017536000
Annuals > 3 > cash Flow > capital Expenditures
523000
Annuals > 3 > cash Flow > cash From Investing
-1870280000
Annuals > 3 > cash Flow > cash From Financing
385112000
Annuals > 3 > cash Flow > net Change In Cash
532368000
Annuals > 3 > ratios > PE
1.4940332978143789
Annuals > 3 > ratios > PB
2.8385451807760766
Annuals > 3 > ratios > ROE
10.72825959380216
Annuals > 3 > ratios > ROA
3.538095321013264
Annuals > 3 > ratios > FCF
2017013000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.8809982952334238
Annuals > 3 > health Score
70
Valuation > metrics > PE
22.7184
Valuation > metrics > PB
3.3492829341345374
Valuation > final Score
76.50717065865463
Valuation > verdict
5.8% Overvalued
Profitability > metrics > ROE
4.493317169570469
Profitability > metrics > ROA
15.58319730829932
Profitability > metrics > Net Margin
0.4730366934683099
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
1.5163534937611742
Risk > metrics > Interest Coverage
5.368709466592931
Risk > final Score
51
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.356628679917274
Liquidity > metrics > Quick Ratio
4.356628679917274
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
66.01215203114096
Prev Valuations > 1
66.82524881339978
Prev Valuations > 2
67.44915232399939
Prev Profitabilities > 0
15
Prev Profitabilities > 1
67
Prev Profitabilities > 2
66
Prev Risks > 0
42
Prev Risks > 1
63
Prev Risks > 2
52
Prev Liquidities > 0
87
Prev Liquidities > 1
94
Prev Liquidities > 2
95
Updated At
2025-12-13T01:18:42.541Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-10
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
1.31
Earnings History > 0 > eps Difference
-1.31
Earnings History > 0 > surprise Percent
-100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
1.17
Earnings History > 1 > eps Estimate
1.04
Earnings History > 1 > eps Difference
0.13
Earnings History > 1 > surprise Percent
12.5
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
1.14
Earnings History > 2 > eps Estimate
1.03
Earnings History > 2 > eps Difference
0.11
Earnings History > 2 > surprise Percent
10.6796
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
1.06
Earnings History > 3 > eps Estimate
0.95
Earnings History > 3 > eps Difference
0.11
Earnings History > 3 > surprise Percent
11.5789
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-11
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.35
Earnings History > 4 > eps Estimate
0.25
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
40
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.92
Earnings History > 5 > eps Estimate
0.93
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-1.0753
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.96
Earnings History > 6 > eps Estimate
0.97
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-1.0309
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.98
Earnings History > 7 > eps Estimate
0.98
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-15
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
1.52
Earnings History > 8 > eps Estimate
1
Earnings History > 8 > eps Difference
0.52
Earnings History > 8 > surprise Percent
52
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-08
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.79
Earnings History > 9 > eps Estimate
0.77
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
2.5974
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.84
Earnings History > 10 > eps Estimate
0.81
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
3.7037
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
1.6
Earnings History > 11 > eps Estimate
1.27
Earnings History > 11 > eps Difference
0.33
Earnings History > 11 > surprise Percent
25.9843
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-15
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
1.56
Earnings History > 12 > eps Estimate
1.46
Earnings History > 12 > eps Difference
0.1
Earnings History > 12 > surprise Percent
6.8493
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.73
Earnings History > 13 > eps Estimate
0.71
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
2.8169
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.79
Earnings History > 14 > eps Estimate
0.78
Earnings History > 14 > eps Difference
0.01
Earnings History > 14 > surprise Percent
1.2821
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.6
Earnings History > 15 > eps Estimate
0.72
Earnings History > 15 > eps Difference
-0.12
Earnings History > 15 > surprise Percent
-16.6667
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-15
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.8
Earnings History > 16 > eps Estimate
0.78
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
2.5641
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.73
Earnings History > 17 > eps Estimate
0.7
Earnings History > 17 > eps Difference
0.03
Earnings History > 17 > surprise Percent
4.2857
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.71
Earnings History > 18 > eps Estimate
0.71
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.67
Earnings History > 19 > eps Estimate
0.65
Earnings History > 19 > eps Difference
0.02
Earnings History > 19 > surprise Percent
3.0769
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-17
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.7
Earnings History > 20 > eps Estimate
0.7
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-10
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.65
Earnings History > 21 > eps Estimate
0.59
Earnings History > 21 > eps Difference
0.06
Earnings History > 21 > surprise Percent
10.1695
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-12
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0.61
Earnings History > 22 > eps Estimate
0.6
Earnings History > 22 > eps Difference
0.01
Earnings History > 22 > surprise Percent
1.6667
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-17
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
3.94
Earnings History > 23 > eps Estimate
0.52
Earnings History > 23 > eps Difference
3.42
Earnings History > 23 > surprise Percent
657.6923
Earnings History > 24 > period
2017-09-30
Earnings History > 24 > report Date
2017-09-30
Earnings History > 24 > date
2017-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.05
Earnings History > 24 > eps Estimate
-0.28
Earnings History > 24 > eps Difference
0.23
Earnings History > 24 > surprise Percent
82.1429
Earnings History > 25 > period
2017-06-30
Earnings History > 25 > report Date
2017-06-30
Earnings History > 25 > date
2017-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.08
Earnings History > 25 > eps Estimate
-0.22
Earnings History > 25 > eps Difference
0.14
Earnings History > 25 > surprise Percent
63.6364
Earnings History > 26 > period
2017-03-31
Earnings History > 26 > report Date
2017-03-31
Earnings History > 26 > date
2017-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.22
Earnings History > 26 > eps Estimate
-0.14
Earnings History > 26 > eps Difference
-0.08
Earnings History > 26 > surprise Percent
-57.1429
Earnings History > 27 > period
2016-12-31
Earnings History > 27 > report Date
2016-12-31
Earnings History > 27 > date
2016-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.16
Earnings History > 27 > eps Estimate
-0.17
Earnings History > 27 > eps Difference
0.01
Earnings History > 27 > surprise Percent
5.8824
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
0.22Next Payout:
Dec 10, 2025Yield:
2.2923 %Main Street Financial Solutions LLC Buys 31,844 Shares of Royalty Pharma PLC $RPRX - MarketBeat
12/12/2025
Main Street Financial Solutions LLC Buys 31,844 Shares of Royalty Pharma PLC $RPRX MarketBeat
Read more →Precision Trading with Royalty Pharma Plc (RPRX) Risk Zones news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$45.9844
Analyst Picks
Strong Buy
4
Buy
2
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 84.81% of the total shares of Royalty Pharma Plc
1.
Morgan Stanley - Brokerage Accounts(10.7807%)
since
2025/06/30
2.
FMR Inc(9.3358%)
since
2025/06/30
3.
Vanguard Group Inc(8.4151%)
since
2025/06/30
4.
BlackRock Inc(5.8823%)
since
2025/06/30
5.
Capital Research & Mgmt Co - Division 3(5.0615%)
since
2025/06/30
6.
Baillie Gifford & Co Limited.(4.1686%)
since
2025/06/30
7.
Swedbank AB(2.8123%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.6029%)
since
2025/07/31
9.
State Street Corp(2.3583%)
since
2025/06/30
10.
Geode Capital Management, LLC(1.8914%)
since
2025/06/30
11.
Vanguard Mid Cap Index Institutional(1.8483%)
since
2025/07/31
12.
American Funds New Perspective A(1.6369%)
since
2025/06/30
13.
Capital Group New Perspective Comp(1.6369%)
since
2025/06/30
14.
Caledonia (Private) Investments Pty Ltd(1.4908%)
since
2025/06/30
15.
Adage Capital Partners Gp LLC(1.3879%)
since
2025/06/30
16.
Morgan Stanley Growth(1.3752%)
since
2025/06/30
17.
Morgan Stanley Inst Growth I(1.3752%)
since
2025/06/30
18.
Morgan Stanley Growth SMA(1.3752%)
since
2025/06/30
19.
MS INVF US Advantage I(1.2506%)
since
2025/07/31
20.
NORGES BANK(1.1646%)
since
2025/06/30
21.
MS INVF US Growth I(1.0612%)
since
2025/07/31
22.
Victory Capital Management Inc.(1.039%)
since
2025/06/30
23.
Capital Group Growth Fnd of Amer Comp(1.0145%)
since
2025/06/30
24.
American Funds Growth Fund of Amer A(1.0145%)
since
2025/06/30
25.
Swedbank Robur Aktiefond Pension(0.9464%)
since
2025/07/31
26.
Fidelity Advisor Equity Growth I(0.9451%)
since
2025/07/31
27.
UBS Asset Mgmt Americas Inc(0.9431%)
since
2025/06/30
28.
Northern Trust Corp(0.9304%)
since
2025/06/30
29.
Vanguard Institutional Extnd Mkt Idx Tr(0.9013%)
since
2025/07/31
30.
Swedbank Robur Transfer 70(0.8549%)
since
2025/07/31
31.
Fidelity VIP Growth Initial(0.8379%)
since
2025/07/31
32.
VictoryShares Free Cash Flow ETF(0.8326%)
since
2025/08/29
33.
Strategic Advisers Fidelity US TtlStk(0.8324%)
since
2025/07/31
34.
Vanguard Value Index Inv(0.7339%)
since
2025/07/31
35.
Charles Schwab Investment Management Inc(0.696%)
since
2025/06/30
36.
Patients Capital Management LLC(0.6912%)
since
2025/06/30
37.
Arrowstreet Capital Limited Partnership(0.6885%)
since
2025/06/30
38.
American Funds American Balanced A(0.6863%)
since
2025/06/30
39.
Newsouth Capital Management Inc(0.6677%)
since
2025/06/30
40.
Amundi(0.6471%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
1.31
Date
2025-09-30
EPS Actual
1.17
EPS Estimate
1.04
EPS Difference
0.13
Surprise Percent
12.5%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.